New Road Map for Treating Exhaustion in Multiple Sclerosis
December 22, 2016
How diabetes drug metformin prevents, suppresses cancer growth
December 22, 2016
Show all

Top 5 of 2016: Skin Cancer 

Here are some of the latest developments in skin cancer in 2016.

Many strides in the fight against skin cancer were made in 2016. These developments included progress in research, awareness and prevention. These are the top 5 skin cancer articles of 2016 from Dermatology Times.

Skin bacteria may fuel cancer cell progression

A study reveals that toxin-producing bacteria like staphylococcus may fuel CTCL; therefore, antibacterial treatment may slow disease progression. Findings could one day change how you treat patients. >> Read more.

High-risk skin cancer needs multidisciplinary management

Immunosuppressed patients have a greater risk for developing high-risk non-melanoma skin cancer, which can typically be more aggressive in this patient population. As such, a multidisciplinary approach is required when contemplating appropriate treatment and management of this patient population. >> Read more.

Dermatologists take a hike in the name of skin cancer

Dermatologists attending the annual meeting for the Florida Society of Dermatology and Dermatologic Surgery, in Naples, took a break from meeting sessions and presentations to hike a three-mile stretch of the beach wearing sun protective clothes and sunscreen, and talking with beachgoers about skin cancer recognition and prevention. >> Read more.

Nonprofit supports skin cancer prevention

Make Big Change is a grassroots nonprofit that focuses on putting dispensers with free sunscreen around public outdoor areas nationwide. The dispensers come with infographics that communicate sun exposure dangers and prevention benefits. >> Read more.

Read full article: Top 5 of 2016: Skin Cancer | Dermatology Times

Read Full Article: Top 5 of 2016: Skin Cancer | Dermatology Times

The health and medical information on our website is not intended to take the place of advice or treatment from health care professionals. It is also not intended to substitute for the users’ relationships with their own health care/pharmaceutical providers.

Comments are closed.